ContraFect (CFRX) Announces 1-for-10 Reverse Stock Split

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. SPY
3. ANT
4. LLY
5. TSLA
6. META
7. FICO
8. ACCV
9. MSFT
10. SPCX

Go back to ContraFect (CFRX) Announces 1-for-10 Reverse Stock Split

ContraFect Announces One-for-Ten Reverse Stock Split

February 4, 2020 7:00 AM EST

YONKERS, N.Y., Feb. 04, 2020 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections, today announced a one-for-ten reverse stock split of its shares of common stock. Stockholders of ContraFect approved an amendment to the Companys Certificate of Incorporation to effect the reverse stock split... More